Align Technology | 563.2100 / -0.34% |
Date/Time | 03/02 / 21:59 |
Chg. / Chg.(%) | -1.9000 / -0.34% |
Bid | 553.8800 / 300 |
Ask | 778.0000 / 100 |
Open | 565.0000 |
Previous Close | 565.1100 |
High | 576.3500 |
Low | 558.0000 |
Volume [USD] | 283,902,673.2523 |
Volume [Units] | 933,310 |
Price fixings | 3533 |
ISIN | US0162551016 |
Security | ALGN |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
London Inter.. | 571.42 | ![]() |
396 |
TradeGate | 471.75 | ![]() |
24 |
Stuttgart | 470.150 | ![]() |
5 |
München | 470.35 | ![]() |
0 |
Düsseldorf | 467.90 | ![]() |
0 |
Frankfurt | 468.3500 | ![]() |
0 |
Berlin | 467.85 | ![]() |
0 |
Vienna Globa.. | 470.00 | ![]() |
0 |
gettex | 468.550 | ![]() |
|
Lang & Schwa.. | 467.30 | ![]() |
|
NASDAQ | 563.2100 | ![]() |
933,310 |
Cboe US | 563.25 | 55,720 | |
IEX | 562.54 | ![]() |
50,305 |
Xetra | 473.25 | 5 | |
Mexico | 11,880.00 | ![]() |
25 |
News
- Lands' End Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call
12:45 - GlobeNewswire - Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
12:45 - GlobeNewswire - Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
12:45 - GlobeNewswire - Palladium One Expands 2021 Drill Programs to 27,000 Meters, Exploration Budget to $11.5 Million and Provides LK Project Update
12:37 - Newsfile Corp - Grocery Outlet Holding Corp. Announces Participation In The UBS Global Consumer and Retail Virtual Conference
12:30 - GlobeNewswire